Clinical Trial Update: Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis [NA]

View source ↗

Summary

A terminated clinical trial comparing two topical formulations (609580 20 vs 609209) in children with atopic dermatitis; results were posted in 2011 describing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• 609209
• 609580 20

Snippet

Sponsor: Cosmetique Active International | Conditions: Atopic Dermatitis | NA | Status: TERMINATED | Results posted: 2011-02-03